Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
about
TNF-alpha inhibitors for ankylosing spondylitisInfliximab is superior to other biological agents for treatment of active ulcerative colitis: A meta-analysisSecukinumab for ankylosing spondylitis and psoriatic arthritisShould axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?Management of the temporomandibular joint in inflammatory arthritis: Involvement of surgical procedures.Work outcome in yet undiagnosed patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis; results of a cross-sectional study among patients with chronic low back pain.Advances in managing ankylosing spondylitisQuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment.Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitisExternal Validation of a Referral Rule for Axial Spondyloarthritis in Primary Care Patients with Chronic Low Back Pain.The Effect of Cigarette Smoke Exposure on the Development of Inflammation in Lungs, Gut and Joints of TNFΔARE MiceEffectiveness of Adalimumab in Non-radiographic Axial Spondyloarthritis: Evaluation of Clinical and Magnetic Resonance Imaging Outcomes in a Monocentric Cohort.Trends in treatment and outcomes of ankylosing spondylitis in outpatient rheumatological care in Germany between 2000 and 2012.Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis.Biologics Use in Asian Indian Patients with Ankylosing Spondylitis: A Physician's Perspective.Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis.99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry studyTNF-α Induced the Enhanced Apoptosis of Mesenchymal Stem Cells in Ankylosing Spondylitis by Overexpressing TRAIL-R2.Polish Medical Society of Radiology and Polish Society of Rheumatology Recommendations for Magnetic Resonance Imaging of Musculoskeletal Disorders in Rheumatology.An overview of investigational new drugs for treating ankylosing spondylitis.Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?The role of IL-17 in the treatment of psoriatic arthritis.Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates.Management of patients with inflammatory bowel disease and spondyloarthritis.Transcriptome analysis of ankylosing spondylitis patients before and after TNF-α inhibitor therapy reveals the pathways affected.Rituximab Can Induce Remission in a Patient with Ankylosing Spondylitis Who Failed Anti-TNF-α Agent.Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study.Have the annual trends of total knee arthroplasty in ankylosing spondylitis patients decreased?Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumab.Association of polymorphisms in TNF and GRN genes with ankylosing spondylitis in a Chinese Han population.Unmet Needs in Axial Spondyloarthritis.Role of Stem Cells in Pathophysiology and Therapy of Spondyloarthropathies-New Therapeutic Possibilities?TNFα blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in Spondyloarthritis.Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study.Efficacy and safety of etanercept in patients from Latin America, Central Europe and Asia with early non-radiographic axial spondyloarthritis.[Treatment of chronic back pain: current standards].Effect of tumor necrosis factor-α inhibitors on ambulatory 24-h blood pressure.Effect of Comedication With Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Retention of Tumor Necrosis Factor Inhibitors in Patients With Spondyloarthritis: A Prospective Cohort Study.Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study.
P2860
Q24186462-1A56A745-5F67-46EC-B105-04E2CEFDBED6Q27006683-CD4BCCE0-8C56-4E4A-9E83-3FC228971203Q28071474-40073E8A-4633-4546-BF64-5BD2BD3407ABQ30239856-7DE706B6-1B20-468B-BFCF-329647B5DFECQ33806696-7B7A6B57-B2FE-4BCA-BB79-637A3C701A59Q33808563-DBA35573-E79A-4CA9-8683-7D21A22BEB81Q34201927-1B5EE00A-07D6-427E-AA8F-75DC3DF126D8Q35154706-11AC0EF7-0C44-4E6A-AC8E-62DD3B10B33FQ35170882-FA54039B-BD7C-404B-906F-74B1B92E31D7Q35705614-60AB8AAF-058A-466F-835D-C4CBA0BF1369Q35829049-9FD882D7-EF5B-42E1-B8C1-F913AB9FC015Q36009390-2F7A98DB-39AE-4548-8C6E-2E7738B37FA4Q36182303-10FD9CE1-4D63-4D60-9E1B-BF43A8580CB3Q36477447-2BCBA8DE-081B-4FE4-8147-7F899D2AE091Q37228801-0BF3CDFD-B152-48BB-99E7-0FAC012E5FB1Q37250836-C12B22CA-6535-43A5-9DE3-F0EDC6427798Q37453012-374044E0-6E16-4018-A6F3-77E2E4A739F8Q37494175-CB5D9F91-3117-43EA-8A56-1C3FA5B137DEQ37611290-2A242D21-2820-48C9-B7A4-9C8C46F1E44DQ38530125-2D3D8299-275B-43D9-B55E-C394D756553EQ38631462-CD3FBA2A-5351-4D61-B657-3689385DEA8FQ38925780-0E0A8040-41D9-40B9-A116-C3FDCC47C34DQ39293096-3E44D423-ED0E-4C5D-BD80-5DF453A63C5AQ40042219-CE74372A-A708-4CF3-B2D7-45D794A508E8Q40054186-D421E113-CBBC-41B4-8813-95FC13D8E072Q40081875-C168E414-0CA1-4C48-91F2-6C067013F36CQ41895311-C94D0CEC-5AF1-4E97-9AE3-1955349399C0Q42425560-D169B410-CE70-4390-8D33-0082CE4B661CQ47104824-CE84BDAE-C20B-49A2-B0CC-FBCA7D720E5AQ48026614-086DE1E9-BF9D-42B9-9323-B76C69DDD80AQ48137341-CF2DC77A-AD5B-45BE-A940-199F3769AE52Q48287506-F5E3CE23-6A0B-44F4-BEBB-905C8F52586FQ48337725-322F8C5B-DCE7-4D1B-8555-EC7F92A1855DQ48628994-D396904D-3BD0-45E3-87DB-50A118327F38Q48653605-375629F9-C401-4BB8-A845-15701E30FA7CQ48738207-B6512E1E-1DDD-404A-83A8-40B2EA47946FQ50456000-8B6F4C26-09F2-4794-9237-7C3CD3057593Q51329120-A45D2A7D-7078-43CB-8EE3-2836FD1502EBQ51714525-6C8E6E37-46D2-4686-8466-7BDE4112E2E5Q53340748-E9706657-2597-48E0-B02B-1DBDECDB4E3D
P2860
Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Efficacy of TNFα blockers in p ...... yloarthritis: a meta-analysis.
@en
type
label
Efficacy of TNFα blockers in p ...... yloarthritis: a meta-analysis.
@en
prefLabel
Efficacy of TNFα blockers in p ...... yloarthritis: a meta-analysis.
@en
P2093
P2860
P1476
Efficacy of TNFα blockers in p ...... dyloarthritis: a meta-analysis
@en
P2093
Angela Zink
Joachim Listing
Joachim Sieper
P2860
P304
P356
10.1136/ANNRHEUMDIS-2014-205322
P407
P50
P577
2014-04-09T00:00:00Z